Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.9, Iss.3, 2003-03, pp. : 94-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Secretases as targets for the treatment of Alzheimer's disease

By Citron M.

Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease

By Bongaerts G.P.A. Lyerly D.M.

Microbial Pathogenesis, Vol. 22, Iss. 4, 1997-04 ,pp. : 253-256

Academic Press

Access to resources Recommend Favorite

A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimer's Disease

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Presenilins as therapeutic targets for the treatment of Alzheimer's disease

By Golde T.E. Younkin S.G.

Trends in Molecular Medicine, Vol. 7, Iss. 6, 2001-06 ,pp. : 264-269

Elsevier

Access to resources Recommend Favorite

Exosomes in Cholesterol Metabolism and Atherosclerosis

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 17, Iss. 3, 2018-02 ,pp. : 185-194

Bentham Science Publishers

Access to resources Recommend Favorite